GGrantIndex
Sort

51,593 grants matching hepatitis

Project 1 - Changes in Gut Microbiome and related Metabolome Across Trajectory of Alzheimer's Disease

$566,446
Rima F Kaddurah-Daouk · Duke University · U19 · FY2021 · AG

Risk Reduction for Young African American IDUs

$566,386
Tulane University Of Louisiana · R01 · FY2002 · DA

HCV Replication and Immune Response in HIV Coinfection

$566,383
David Richard Gretch · University Of Washington · R01 · FY2006 · AI

(PQ8) Predicting immune-related toxicity in the adjuvant melanoma setting with checkpoint inhibition

$566,338
Iman Osman · New York University School Of Medicine · R01 · FY2020 · CA

Regulation of lipid metabolism in pulmonary Type 2 cells

$566,268
Itsaso Garcia-Arcos · Suny Downstate Medical Center · R01 · FY2023 · HL

The role of cancer stem cells in liver cancer heterogeneity and subtypes

$566,077
Xin Wang · Division Of Basic Sciences - Nci · ZIA · FY2010 · CA

Molecular signatures for liver cancer diagnosis and treatment stratification

$566,077
Xin Wang · Division Of Basic Sciences - Nci · ZIA · FY2010 · CA

Technology-Dev-Core

$565,983
Sally M McFall · Northwestern University · U54 · FY2021 · EB

Geography, networks, and risk in disease transmission

$565,980
Richard B Rothenberg · Georgia State University · R01 · FY2008 · DA

See, Reach, Treat Tumor-Optimized Transarterial Chemoembolization Drug Delivery

$565,961
Nikhil Bhagat · Johns Hopkins University · R01 · FY2011 · CA

Quantifying Body Composition and Liver Disease in Children using Free-Breathing MRI and MRE

$565,869
Holden H Wu · University Of California Los Angeles · R01 · FY2022 · DK

Epidemiologic Study of the Effectiveness of an ADF in Reducing Opioid Abuse

$565,845
Jennifer R Havens · University Of Kentucky · R01 · FY2012 · DA

Genetic and Metabolic Basis of Familial Lipodystrophies

$565,758
Abhimanyu Garg · Ut Southwestern Medical Center · R01 · FY2008 · DK

Neural Circuits, Kinetics and Energetics HTS of Human iPSC-Neurons, -Microglia, and -Astrocytes: AI-Enabled Platform for Target ID, and Drug Discovery and Toxicity (e.g., Cancer Chemo & HIV ARTs)

$565,745
Jeffrey H. Price · Vala Sciences, Inc. · R44 · FY2023 · MH

Lymphatics in the liver

$565,740
Yasuko Iwakiri · Yale University · R01 · FY2024 · DK

METHADONE AND HIV DRUG INTERACTIONS

$565,729
Evan D Kharasch · Washington University · R01 · FY2009 · DA

Does insulin sensitivity impact the potential of metformin to slow aging?

$565,721
Benjamin Francis Miller · Oklahoma Medical Research Foundation · R01 · FY2024 · AG

Glucose Metabolism in Adults Prenatally Exposed to Diabetogenic Pollutants

$565,563
Philippe Adam Grandjean · Harvard School Of Public Health · R01 · FY2017 · ES

Epigenetic regulation of T cell differentiation during infection

$565,557
John Justin Milner · Univ Of North Carolina Chapel Hill · R01 · FY2024 · AI

Retrovial Infections of the Nervous System in Peru

$565,527
Joseph Raymond Zunt · University Of Washington · R01 · FY2008 · NS

Project 3: Non-invasive assessment of liver fibrosis stage and progression in obesity and diabetes: a Hispanic population study

$565,502
Laura Beretta · University Of Tx Md Anderson Can Ctr · P50 · FY2019 · CA

Transcriptional regulatory mechanisms in B cell development and leukemogenesis

$565,455
Robert G Roeder · Rockefeller University · R01 · FY2015 · CA

Transcriptional regulatory mechanisms in B cell development and leukemogenesis

$565,455
Robert G Roeder · Rockefeller University · R01 · FY2016 · CA

Transcriptional regulatory mechanisms in B cell development and leukemogenesis

$565,455
Robert G Roeder · Rockefeller University · R01 · FY2017 · CA

Role of liver fat and fibrosis in human CVD risk phenotypes.

$565,448
Rohit Loomba · University Of California, San Diego · P01 · FY2022 · HL